Uwe Grether

11 Patents

• US126177682026

  Radiolabeled Cannabinoid Receptor 2 Ligand

  ETH ZUERICH

  0 cites
• US125772572026

  Heterocyclic Compounds

  Hoffmann-la Roche Inc.

  0 cites
• US122811242025

  Heterocyclic Compounds as Monoacylglycerol Lipase Inhibitors

  Hoffmann-la Roche Inc.

  0 cites
• US121801962024

  Azetidine-substituted Pyridine and Pyrazine Compounds as Inhibitors of Cannabinoid Receptor 2

  EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH

  0 cites
• US120714202024

  Pyridine and Pyrazine Compounds as Inhibitors of Cannabinoid Receptor 2

  ETH ZUERICH

  0 cites
• US119997102024

  Radiolabeled Cannabinoid Receptor 2 Ligand

  ETH ZUERICH

  0 cites
• US119816612024

  Heterocyclic Compounds

  Hoffmann-la Roche Inc.

  0 cites
• US118143752023

  Heterocyclic Compounds

  Hoffmann-la Roche Inc.

  0 cites
• US118021332023

  Heterocyclic Compounds as Monoacylglycerol Lipase Inhibitors

  Hoffmann-la Roche Inc.

  0 cites
• US116552432023

  Pyridine and Pyrazine Derivatives as Preferential Cannabinoid 2 Agonists

  EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH

  0 cites
• US116083472023

  Octahydropyrido[1,2-alpha]pyrazines as MAGL Inhibitors

  Hoffmann-la Roche Inc.

  0 cites